The 2026 cannabis stock rally has produced a clear analyst favorite. Village Farms International (NASDAQ: VFF) is leading multiple sell-side and independent buy lists heading into the second half of the year, with investment commentators citing its international leverage, industry-leading gross margins, and exposure to a Schedule III tailwind that more diversified peers cannot match. After a punishing five-year stretch for cannabis equities, 2026 is shaping up as a stock picker's market — and VFF is the name analysts keep picking first.
Why Village Farms, and Why Now
Cannabis stocks trade at valuations that would look inexpensive in almost any other high-margin industry. Village Farms is the rare operator that has matched that valuation case with operational results. The company built its cannabis business on top of a long-running greenhouse vegetable operation, giving it a cost structure and cultivation discipline that pure-play cannabis producers have struggled to match.
Advertisement
In Canada, Village Farms' Pure Sunfarms subsidiary has been a top-three flower brand by retail share for multiple consecutive quarters. Domestic cannabis prices firmed in 2025, with the flower and pre-roll categories seeing sustained year-on-year increases that have supported improving margins for the operators best positioned to take advantage. VFF's gross margins on its Canadian cannabis business have remained among the highest reported by any publicly traded producer.
Internationally, the company has been quietly building export and partnership infrastructure in Germany, the U.K., the Netherlands, and Australia. Europe is emerging as a major long-term opportunity for cannabis companies, and VFF's lower production-cost base gives it a structural advantage over European producers who must build vertically integrated supply chains from scratch.
The Schedule III Tailwind
If the Justice Department's federal rescheduling of cannabis from Schedule I to Schedule III survives the legal challenge filed by attorneys general in Indiana, Nebraska, and Louisiana, U.S. multi-state operators stand to gain meaningful federal tax relief from the elimination of Section 280E. Village Farms benefits indirectly: improved sector economics tend to lift cannabis equities broadly, and the company's U.S. CBD and hemp businesses have a clearer regulatory path under a less restrictive federal framework.
VFF is not a pure U.S. MSO play, however. Investors looking for direct exposure to 280E relief typically gravitate toward Trulieve, Green Thumb, or Curaleaf. Village Farms' appeal is different — it offers a way to participate in the cannabis trade without taking on the political and legal risk of being a federally illegal U.S. business.
The cannabis market moves weekly.
Price crashes, new brands, and policy shifts — all in one email.
What the Analysts Are Modeling
Investment commentators tracking the 2026 cannabis trade point to several factors when explaining VFF's place at the top of their lists:
The company's international revenue mix is rising. Europe alone is projected to become a multi-billion-euro medical and adult-use market over the next five years, and Village Farms has positioned itself as a supply partner rather than an operator burdened by retail and licensing complexity in each jurisdiction.
The company's leverage profile is healthier than most cannabis peers. Where many U.S. MSOs carry heavy debt loads that limit their flexibility, VFF's balance sheet allows for capital allocation to growth markets without the dilution risk that has hammered cannabis equity holders over the last five years.
The company has demonstrated profitability discipline. Cannabis operators that produced earnings — not just adjusted EBITDA — have been rewarded by the market in 2026. VFF's track record on this metric has narrowed the gap between its trading multiple and the multiples awarded to consumer-staples peers.
Advertisement
The Risks Worth Naming
No 2026 cannabis stock is risk-free, and Village Farms is no exception. As global producers continue to scale up while major import markets face potential near-term constraints on growth, oversupply is likely to become a common theme in the coming year. VFF's exposure to Canadian wholesale pricing is meaningful, and a renewed price war in Canada would compress the very margins that have made the stock attractive.
The company's U.S. exposure to CBD and hemp also carries regulatory risk. The 2026 Farm Bill debate, ongoing FDA enforcement around minor cannabinoids, and state-level bans on hemp-derived THC products all have the potential to affect a slice of revenue that the market has begun to value more highly post-rescheduling.
Finally, the broader cannabis equity trade remains correlated to federal policy news flow. Cannabis stocks rallied through the spring of 2026 on rescheduling optimism. If the D.C. Circuit vacates the DOJ's reclassification, that rally is at risk of unwinding, and high-quality operators like VFF would likely not be spared.
Other 2026 Cannabis Stock Picks
Village Farms leads multiple analyst lists, but it is not alone. Decibel Cannabis Company (TSXV: DB, OTCQB: DBCCF) is named as a complementary Canadian pick on premium-segment growth. High Tide (NASDAQ: HITI) and SNDL (NASDAQ: SNDL) remain preferred Canadian retail names positioned to benefit from continued consolidation — High Tide alone passed 222 Canna Cabana stores in May 2026.
On the U.S. side, Trulieve, Green Thumb Industries, and Cresco Labs are the most-cited Schedule III beneficiaries. Investors looking at ancillary exposure typically include Innovative Industrial Properties (IIPR) and Scotts Miracle-Gro's Hawthorne division.
What This Means for Investors
For investors who have watched cannabis stocks underperform every reasonable benchmark since the 2018 Canadian legalization peak, the 2026 setup is finally starting to look different. Industry fundamentals are stabilizing. Federal policy is moving — slowly, contested, but moving. International markets are opening. And companies with disciplined balance sheets and global cost structures are positioned to capture more of the upside than the broader sector ever did.
Village Farms is not the only way to play the trade. It is, however, the name analysts trust most when asked to pick a single 2026 cannabis stock for a generalist portfolio.
Key Takeaways
- Village Farms (NASDAQ: VFF) tops multiple 2026 analyst buy lists thanks to international leverage, healthy margins, and a clean balance sheet.
- The 2026 cannabis stock rally remains tied to Schedule III rescheduling and the legal challenge brought by Indiana, Nebraska, and Louisiana.
- Other commonly recommended 2026 names include Decibel Cannabis, High Tide, SNDL, Trulieve, and Green Thumb.
- Canadian wholesale price compression and U.S. hemp regulation remain the most-cited risks for VFF specifically.
This article is informational and does not constitute investment advice. Investors should consult a licensed financial professional before making any cannabis-related investment decisions.
Explore cannabis news, find dispensaries, and join the community at Budpedia.
Liked this? There's more every Friday.
The Budpedia Weekly: cannabis laws, science, deals, and strain reviews in your inbox.